
    
      Main end-point is negative sputum conversion rate after one month in patients on V7 vs
      placebo arm, both arms will receive conventional anti-tuberculosis chemotherapy consisting of
      1st and/or 2nd line TB drugs according to baseline diagnosis
    
  